FdaApplication
NDA 211241
Identifiers
- fda_app_no: NDA211241
Properties
| Property | Value |
|---|---|
| applicant_name | SENTYNL THERAPEUTICS INC |
| application_type | NDA |
| approval_date | 2026-01-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZYCUBO | COPPER HISTIDINATE | 2.9MG/VIAL | POWDER;SUBCUTANEOUS |
1 product